Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies

G Schierhout, S McGregor, A Gessain… - The Lancet Infectious …, 2020 - thelancet.com
Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

K Verdonck, E González, S Van Dooren… - The Lancet infectious …, 2007 - thelancet.com
Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …

HTLV-1 and Co-infections

C Rosadas, GP Taylor - Frontiers in Medicine, 2022 - frontiersin.org
Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell
infection in humans, impacting the host immune response. This virus causes a range of …

Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection

L Einsiedel, F Chiong, H Jersmann, GP Taylor - Retrovirology, 2021 - Springer
The lung is one of several organs that can be affected by HTLV-1 mediated inflammation.
Pulmonary inflammation associated with HTLV-1 infection involves the interstitium, airways …

Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study

J Marinho, B Galvao-Castro… - JAIDS Journal of …, 2005 - journals.lww.com
Objectives: To investigate whether infection with human T-lymphotropic virus type 1 (HTLV-
1) increases the risk of tuberculosis. Design: A case-control study. Setting: City of Salvador …

HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru

K Verdonck, E Gonzalez, G Henostroza… - … of Tuberculosis and …, 2007 - ingentaconnect.com
SETTING: Tuberculosis (TB) and human T-lymphotropic virus 1 (HTLV-1) are frequent in
Peru. The prevalence of HTLV-1 among Peruvian TB patients is unknown. OBJECTIVE: To …

Predicting and designing epitope ensemble vaccines against HTLV-1

S Alam, MK Hasan, OHB Manjur, AM Khan… - Journal of integrative …, 2019 - degruyter.com
The infection mechanism and pathogenicity of Human T-lymphotropic virus 1 (HTLV-1) are
ambiguously known for hundreds of years. Our knowledge about this virus is recently …

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I-and II-infected blood donors

EL Murphy, SA Glynn, J Fride, RA Sacher… - Journal of Infectious …, 1997 - academic.oup.com
Disease associations of human T lymphotropic virus types I and II (HTLV-I and-II) infection
were studied in 154 HTLV-I-infected, 387 HTLV-II-infected, and 799 uninfected blood …

Clinical and public health implications of human T-lymphotropic virus type 1 infection

N Legrand, S McGregor, R Bull, S Bajis… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru

K Verdonck, E Gonzalez, W SCHROOTEN… - Epidemiology & …, 2008 - cambridge.org
The purpose of this study was to assess the association between human T-lymphotropic
virus 1 (HTLV-1) and a lifetime history of active tuberculosis (TB) among relatives of HTLV-1 …